Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.

Runhui WuXiaoling WangXielan ZhaoYanli ChengZeping ZhouJing SunMing XuWenqian LiJianwen XiaoFenge YangYun ChenWeiqun XuJing HuangChuanrong MaWenlin GaiLiangzhi XieRenchi Yang

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

Omfiloctocog alfa was efficacious and well tolerated for the prevention and treatment of bleeding in Chinese pediatric PTPs with severe hemophilia A.

Keyphrases

recombinant human
replacement therapy
early onset
young adults
atrial fibrillation
drug induced
combination therapy
childhood cancer